← Open Payments lookup

DAVID PFALZER: Open Payments

NPI 1932410206 · WARSAW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$981 in 60 payments from 11 companies in 2025. Trend: 2023 $1,004 · 2024 $625 · 2025 $981

Food & beverage: $981
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$255
Vanda Pharmaceuticals Inc.7$167
ABBVIE INC.9$161
Alkermes, Inc.9$138
E.R. Squibb & Sons, L.L.C.4$73
Otsuka America Pharmaceutical, Inc.2$47
Neurocrine BioSciences, Inc.2$46
Lundbeck LLC1$30
Teva Pharmaceuticals USA, Inc.1$22
Janssen Pharmaceuticals, Inc1$21

Products named: CAPLYTA, FANAPT, VRAYLAR, ARISTADA, COBENFY, ABILIFY ASIMTUFII, INGREZZA, REXULTI.

Industry payments across NY — which companies pay providers there.